COVID-19 2022 update: transition of the pandemic to the endemic phase
- PMID: 35650595
- PMCID: PMC9156835
- DOI: 10.1186/s40246-022-00392-1
COVID-19 2022 update: transition of the pandemic to the endemic phase
Abstract
COVID-19, which is caused by the SARS-CoV-2, has ravaged the world for the past 2 years. Here, we review the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase. We are particularly concerned by the lack of solid information from the initial phases of the pandemic that highlighted the necessity for better preparation to face similar future threats. On the other hand, we are gratified by the progress into human genetic susceptibility investigations and we believe now is the time to explore the transition from the pandemic to the endemic phase. The latter will require worldwide vigilance and cooperation, especially in emerging countries. In the transition to the endemic phase, vaccination rates have lagged and developed countries should assist, as warranted, in bolstering vaccination rates worldwide. We also discuss the current status of vaccines and the outlook for COVID-19.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


References
-
- National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. CDC COVID-19 Science Briefs. Atlanta (GA): Centers for Disease Control and Prevention (US); 2020–. Science Brief: Omicron (B.1.1.529) Variant. 2021 Dec 2. - PubMed
-
- Colona VL, Vasiliou V, Watt J, Novelli G, Reichardt JKV. Update on human genetic susceptibility to COVID-19: susceptibility to virus and response. Hum Genom. 2021;15(1):57. doi: 10.1186/s40246-021-00356-x.Erratum.In:HumGenomics.2021Sep18;15(1):59. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous